单胺氧化酶抑制剂

用来治疗临床抑郁症的一种单胺氧化酶抑制剂（商标是Marplan）。

A monoamine oxidase inhibitor ( trade name Marplan ) that is used to treat clinical depression .

吗氯贝胺，化学名称为4-氯-N-[2-（4-吗啉基）乙基]苯甲酰胺，是新型可逆单胺氧化酶抑制剂，能有效治疗抑郁症，疗效显著，不良反应少。

Moclobemide , 4-chloro-N - [ 2 - ( 4-morpholinyl ) ethyl ] benzamide , is one typical drug of the new kind of reversible monoamine oxidase inhibitor . It is applied in treating depressant effectively .

单胺氧化酶抑制剂治疗卒中后抑郁症临床观察

Clinic observation of the effects of monoamine oxidase inhibitor on poststroke depression

新型单胺氧化酶抑制剂吗氯贝胺的合成

Synthesis of a New Style Monamine Oxidase Inhibition Moclobemide

目前临床常用的抗抑郁症药包括三环类、四环类、神经递质类抑制剂、单胺氧化酶抑制剂等药物。

At present in the Western clinic , the commonly used antidepressant drugs include tricyclic , the fourth ring category , neurotransmitter inhibitors , monoamine Oxidase inhibitors and other drugs .

目的：分析三环类抗抑郁药丙咪嗪和单胺氧化酶抑制剂吗氯贝胺治疗抑郁障碍患者的早期反应是否可以预测药物的远期疗效。

Objective : To explore the feasibility to predict the effectiveness of the late stage of anti-depression treatment based on the early stage of the treatment response with imipramine ( tricyclic antidepressant ) and moclobemide ( MAOI antidepressant ) .

单胺氧化酶B抑制剂对衰老模型小鼠抗氧化作用的探讨

The antioxidative effect of monoamine oxidase B inhibitors on aging model mice induced by D galactose

本文研完了大白鼠脑内单胺氧化酶内源性抑制剂（MAOI），并确定它存在于大白鼠脑105000g离心的上清液中。

Endogenous inhibitor of monoamine oxidase ( MAOI ) in rat brain has been studied with biochemical methods . MAOI was found in rat brain 105000g supernatant .

大白鼠脑内单胺氧化酶内源性抑制剂的研究

Studies of Endogenous Inhibitor of Monoamine Oxidase in Rat Brain

帕金森病人脑脊液神经毒性及单胺氧化酶-B抑制剂和多巴胺激动剂的保护作用的研究

Study on the Neurotoxicity of CSF from Patients with Parkinson Disease and the Protection of MAO-B Inhibitor and Dopamine Agonist Against the Toxicity

单胺氧化酶（MAO）抑制剂1957年被推荐用来治疗抑郁症。

Monoamine oxidase ( MAO ) inhibitors were introduced into therapy for the treatment of depression in 1957 .

本文对1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）在恒河猴帕金森病（PD）动物模型上的应用进行了研究，并对B型单胺氧化酶（MAO-B）抑制剂Deprenyl拮抗MPTP的神经毒性作用进行了探讨。

The use of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) created a parkinsonian animal model in rhesus monkey , and the mechanism of action of MPTP was studied through testing monoamine oxidase B ( MAO-B ) inhibitor , deprenyl , against the neurotoxicity of MPTP .